42 results
DRSLTR
AMYT
Amryt Pharma Plc
28 May 20
Correspondence regarding draft registration statement
12:00am
. The entitlement is variable depending on the date of achievement of the milestone, if at all; and
Revenue targets – CVR holders carry an aggregate
6-K
EX-99.1
AMYT
Amryt Pharma Plc
6 Aug 20
Amryt Announces Q2 2020 Results and Issues Positive Revenue Guidance for Fy 2020
9:43am
to zero if before July 1, 2022
Revenue targets
US$35,000,000 upon FILSUVEZ revenues exceeding US$75,000,000 in any 12-month period prior to June 30, 2024 … of when such revenue targets may occur may change. Such changes may have a material impact on the expected cash flows of the CVRs.
Amryt reviews
424B3
AMYT
Amryt Pharma Plc
4 May 22
Prospectus supplement
8:35am
targets are exceeded, additional performance stock units will be issued and vest in accordance with the terms of the relevant performance stock units … to zero if before July 1, 2022
Revenue targets
US$35,000,000 upon Oleogel-S10 revenues exceeding US$75,000,000 in any 12-month period prior to June 30
6-K
EX-99.1
AMYT
Amryt Pharma Plc
5 May 21
Amryt Reports Record Q1 2021 Financial and Operating Results
9:40am
% of the amount due if approval is obtained before December 31, 2021, with a sliding scale on a linear basis to zero if before July 1, 2022
Revenue targets
US … requirements and the commercial success of the product), the timing of when such revenue targets may occur may change. Such changes may have a material
6-K
EX-99.1
AMYT
Amryt Pharma Plc
6 Aug 21
Amryt Reports Record Q2 2021 Results and Raises FY 2021 Guidance
8:18am
, with a sliding scale on a linear basis to zero if before July 1, 2022
Revenue targets US$35,000,000 upon Oleogel-S10 revenues exceeding US$75,000,000 in any … of when such revenue targets may occur may change. Such changes may have a material impact on the assessment of the expected cash flows of the CVRs.
Amryt
6-K
EX-99.2
cl35pbyv 3wlojs
13 Sep 21
Current report (foreign)
8:48am
424B3
zyc580coj2me0w 8l0c9
6 Aug 21
Prospectus supplement
8:17am
424B3
3ergszduoe389a
6 Aug 21
Prospectus supplement
8:18am
6-K
EX-99.3
f1yolbikcmax8i4akme
22 Nov 21
Amryt Announces the Cancellation of Admission of its Ordinary Shares to Trading on AIM
7:37am
424B3
yja qwbq0j08vy12dxa
3 Nov 21
Prospectus supplement
7:33am
6-K
EX-99.1
s4nx6t
5 Nov 20
Amryt Reports Record Q3 2020 Results - Raising FY 2020 Revenue Guidance
7:55am
6-K
EX-99.1
zpge592y2 v3
4 May 22
Amryt Reports Record Q1 2022 Results
7:43am
424B3
62wvroh
3 Nov 21
Prospectus supplement
7:32am
6-K
EX-99.5
lcs1ipl7j5mbtjon
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.1
oq0hfzf2
3 Nov 21
Amryt Reports Strong Q3 2021 Results
7:31am
424B3
gm2d0y
9 Mar 22
Prospectus supplement
9:26am
424B3
f4xt9djb 0sp
4 Mar 21
Prospectus supplement
8:38am
6-K
EX-99.1
n9z7c3
9 Mar 22
Amryt Announces 22% growth in FY 2021 Revenues to $222.5M
9:23am
424B3
o1339u2n ok8v5p15c2
2 Jun 21
Prospectus supplement
10:08am
6-K
EX-99.7
tytkl
3 Nov 22
Current report (foreign)
7:44am